Immunovant
IMVT
IMVT
110 hedge funds and large institutions have $407M invested in Immunovant in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 120 → 110 (-10)
32% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 31
38% less capital invested
Capital invested by funds: $653M → $407M (-$246M)
Holders
110
Holding in Top 10
1
Calls
$56.4M
Puts
$8.84M
Top Buyers
| 1 | +$30.2M | |
| 2 | +$9.54M | |
| 3 | +$9.49M | |
| 4 |
Morgan Stanley
New York
|
+$8.35M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.19M |
Top Sellers
| 1 | -$102M | |
| 2 | -$8.89M | |
| 3 | -$8.06M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$7.49M |
| 5 |
BlackRock
New York
|
-$6.15M |